November 14, 2023CorporateTerumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes
November 11, 2023CorporateTerumo India Advances Liver Cancer Care in India with the Launch of Occlusafe™ & LifePearl™
Investors Japanese Financial Results for the First Half of the Fiscal Year Ending 3/2024 November 14, 2023 IR Library Audio Webcast Stock Quote Prime Market of TSE: Last Trade JPY Change JPY (%) Volume View Chart Top Management Message Shinjiro Sato, President and CEO GS26: 5-Year Growth strategy 2022 - 2026 Terumo Report Sustainability What's New November 16, 2023 Q&A regarding Financial Results for the First Half of FYE 3/2024 November 15, 2023 Audio webcast regarding Financial Results for the First Half of FYE 3/2024 November 14, 2023 Presentation regarding Financial Results for the First Half of FYE 3/2024 November 02, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.38 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) September 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 108.68 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
November 02, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 112.38 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
September 04, 2023 Notice Concerning the Status of the Acquisition of Own Shares (PDF 108.68 KB) (Acquisition of the company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
